Pharmacological effect of cepharanthine on SARS-CoV-2–induced disease in a Syrian hamster model
Authors:
- Takayuki UematsuTUTakayuki Uematsu
- Reiko Takai-TodakaRTReiko Takai-Todaka
- Kei HagaKHKei Haga
- Hideyuki KobayashiHKHideyuki Kobayashi
- Makiko ImajimaMIMakiko Imajima
- Noritada KobayashiNKNoritada Kobayashi
- Kazuhiko KatayamaKazuhiko Katayama
- Hideaki HanakiHHHideaki Hanaki
- 27 August 2024
- journal article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 31 (1) , 102505
Abstract
No abstract availableFunding Information
- Kowa Co Ltd
This publication has 45 references indexed in Scilit:
- Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19JAMA Network Open, 2024
- Clinical Characteristics, Diagnosis, and Therapeutics of COVID-19: A ReviewCurrent Medical Science, 2023
- Targeting SARS-CoV-2 and host cell receptor interactionsAntiviral Research, 2022
- ACE2: The Major Cell Entry Receptor for SARS-CoV-2Lung, 2020
- Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)JAMA Cardiology, 2020
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)JAMA, 2020
- Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy CasesJAMA Cardiology, 2020
- Suppression of tumor necrosis factor α–induced matrix metalloproteinase 9 production in human salivary gland acinar cells by cepharanthine occurs via down‐regulation of nuclear factor κB: A possible therapeutic agent for preventing the destruction of the acinar structure in the salivary glands of Sjögren's syndrome patientsArthritis & Rheumatism, 2002
- Cepharanthine activates caspases and induces apoptosis in Jurkat and K562 human leukemia cell linesJournal of Cellular Biochemistry, 2001
- Overcoming CPT-11 resistance by using a biscoclaurine alkaloid, cepharanthine, to modulate plasma trans-membrane potentialInternational Journal of Cancer, 1997